Association of human TLR1 and TLR6 deficiency with altered immune responses to bcg vaccination in south african infants

PLoS Pathogens

Volumn 7, Issue 8, 2011, Pages

  Randhawa, April Kaur ^a   Shey, Muki S ^b   Keyser, Alana ^b   Peixoto, Blas ^c   Wells, Richard D ^a   de Kock, Marwou ^b   Lerumo, Lesedi ^b   Hughes, Jane ^b   Hussey, Gregory ^b   Hawkridge, Anthony ^b   Kaplan, Gilla ^c   Hanekom, Willem A ^b   Hawn, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 6; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 6; TLR6 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL IMMUNITY; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; EX VIVO STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOREGULATION; INFANT; INNATE IMMUNITY; LIGAND BINDING; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARMACOGENETICS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; TH1 CELL; TUBERCULOSIS; BIOSYNTHESIS; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

BCG VACCINE; HUMANS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-6; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 6; TUBERCULOSIS;

EID: 80052310730     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002174     Document Type: Article

References (59)

1. WHO, (2006) World Health Organization, Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva.
2. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, et al. (1995) The Efficacy of Bacillus Calmette-Guerin Vaccination of Newborns and Infants in the Prevention of Tuberculosis: Meta-Analyses of the Published Literature. Pediatrics 96: 29-35.
3. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, et al. (1994) Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature. JAMA 271: 698-702.
4. Black G, Dockrell H, Crampin A, Floyd S, Weir R, et al. (2001) Patterns and Implications of Naturally Acquired Immune Responses to Environmental and Tuberculous Mycobacterial Antigens in Northern Malawi. J Infect Dis 184: 322-329.
5. Black GF, Rosemary EW, Floyd S, Bliss L, Warndorff DK, et al. (2002) BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. LANCET 359: 1393-1401.
6. Lagranderie MR, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M, (1996) Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 64: 1-9.
7. van der Eijk EA, van de Vosse E, Vandenbroucke JP, van Dissel JT, (2007) Heredity versus Environment in Tuberculosis in Twins: The 1950s United Kingdom Prophit Survey Simonds and Comstock Revisited. Am J Respir Crit Care Med 176: 1281-1288.
8. Fortin A, Abel L, Casanova JL, Gros P, (2007) Host Genetics of Mycobacterial Diseases in Mice and Men: Forward Genetic Studies of BCG-osis and Tuberculosis. Annu Rev of Genomics Hum Genet 8: 163-192.
9. Vannberg FO, Chapman SJ, Hill AV, (2011) Human genetic susceptibility to intracellular pathogens. Immunol Rev 240: 105-116.
10. Berrington WR, Hawn TR, (2007) Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol Rev 219: 167-186.
11. Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I,et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 42: 739-741.
12. Cobat A, Gallant CJ, Simkin L, Black GF, Stanley K, et al. (2009) Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. J Exp Med 206: 2583-2591.
13. Sepulveda RL, Heiba IM, King A, Gonzalez B, Elston RC, et al. (1994) Evaluation of tuberculin reactivity in BCG-immunized siblings. Am J Respir Crit Care Med 149: 620-624.
14. Stein CM, Zalwango S, Malone LL, Won S, Mayanja-Kizza H, et al. (2008) Genome Scan of M. tuberculosis Infection and Disease in Ugandans. PLoS ONE 3: e4094.
15. Cobat A, Gallant Caroline J, Simkin L, Black Gillian F, Stanley K, et al. (2010) High Heritability of Antimycobacterial Immunity in an Area of Hyperendemicity for Tuberculosis Disease. J Infect Dis 201: 15-19.
16. Jepson A, Fowler A, Banya W, Singh M, Bennett S, et al. (2001) Genetic Regulation of Acquired Immune Responses to Antigens of Mycobacterium tuberculosis: a Study of Twins in West Africa. Infect Immun 69: 3989-3994.
17. Stein Catherine M, Guwatudde D, Nakakeeto M, Peters P, Elston Robert C, et al. (2003) Heritability Analysis of Cytokines as Intermediate Phenotypes of Tuberculosis. J Infect Dis 187: 1679-1685.
18. Finan C, Ota MOC, Marchant A, Newport MJ, (2008) Natural Variation in Immune Responses to Neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian Infants. PLoS ONE 3: e3485.
19. Lalor M, Ben-Smith A, Gorak-Stolinska P, Weir R, Floyd S, et al. (2009) Population Differences in Immune Responses to Bacille Calmette-Guérin Vaccination in Infancy. J Infect Dis 199: 795-800.
20. Misch EA, Hawn TR, (2008) Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci 114: 347-360.
21. Randhawa AK, Hawn TR, (2008) Toll-like receptors: their roles in bacterial recognition and respiratory infections. Expert Rev Anti Infect Ther 6: 479-495.
22. Medzhitov R, Preston-Hurlburt P, Janeway CA, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
23. Kawai T, Akira S, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
24. Iwasaki A, Medzhitov R, Regulation of Adaptive Immunity by the Innate Immune System. Science 327: 291-295.
25. Manicassamy S, Pulendran B, (2009) Modulation of adaptive immunity with Toll-like receptors. Semin Immunol. 21: 185-193.
26. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, et al. (2007) Cutting Edge: A Common Polymorphism Impairs Cell Surface Trafficking and Functional Responses of TLR1 but Protects against Leprosy. J Immunol 178: 7520-7524.
27. Hawn Thomas R, Misch EA, Dunstan Sarah J, Thwaites Guy E, Lan Nguyen TN, et al. (2007) A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 37: 2280-2289.
28. Misch E, MacDonald M, Ranjit C, Sapkota B, Siddiqui M, et al. (2008) Human TLR 1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis 2: e231.
29. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, et al. (2004) The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23: 219-223.
30. Schroder NWJ, Diterich I, Zinke A, Eckert J, Draing C, et al. (2005) Heterozygous Arg753Gln Polymorphism of Human TLR-2 Impairs Immune Activation by Borrelia burgdorferi and Protects from Late Stage Lyme Disease. J Immunol 175: 2534-2540.
31. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA, (2000) A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection. Infect Immun 68: 6398-6401.
32. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, et al. (2007) A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39: 523-528.
33. Shey MS, Randhawa AK, Bowmaker M, Smith E, Scriba TJ, et al. (2010) Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion. Genes Immun 11: 561-572.
34. Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, et al. (2008) Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis. Am J Respir Crit Care Med 178: 710-720.
35. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
36. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, et al. (2003) A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease. J Exp Med 198: 1563-1572.
37. Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, et al. (2005) Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci U S A 102: 2487-2489.
38. Hawn T, Dunstan S, Thwaites G, Simmons C, Thuong N, et al. (2006) A Polymorphism in Toll-Interleukin 1 Receptor Domain Containing Adaptor Protein Is Associated with Susceptibility to Meningeal Tuberculosis. J Infect Dis 194: 1127-1134.
39. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, et al. (2006) Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 3: e20.
40. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, et al. (2007) Full-Exon Resequencing Reveals Toll-Like Receptor Variants Contribute to Human Susceptibility to Tuberculosis Disease. PLoS ONE 2: e1318.
41. Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI, (2007) The Polymorphism P315L of Human Toll-Like Receptor 1 Impairs Innate Immune Sensing of Microbial Cell Wall Components. J Immunol 178: 6387-6394.
42. Weir RE, Black GF, Nazareth B, Floyd S, Stenson S, et al. (2006) The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi. Clin Exp Immunol 146: 390-399.
43. Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, et al. (2004) The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis 84: 347-352.
44. Wong SH, Gochhait S, Malhotra D, Pettersson FH, Teo YY, et al. (2010) Leprosy and the Adaptation of Human Toll-Like Receptor 1. PLoS Pathog 6: e1000979.
45. Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F, (2008) Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev 226: 112-131.
46. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, et al. (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041-1048.
47. Redford PS, Murray PJ, O'Garra A, (2011) The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol 4: 261-270.
48. Medzhitov R, Horng T, (2009) Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703.
49. Bali P, (2004) Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 199: 227-250.
50. Pulendran B, (2005) Variegation of the Immune Response with Dendritic Cells and Pathogen Recognition Receptors. J Immunol 174: 2457-2465.
51. Ernst JD, (1998) Macrophage Receptors for Mycobacterium tuberculosis. Infect Immun 66: 1277-1281.
52. Randhawa AK, Ziltener HJ, Merzaban JS, Stokes RW, (2005) CD43 Is Required for Optimal Growth Inhibition of Mycobacterium tuberculosis in Macrophages and in Mice. J Immunol 175: 1805-1812.
53. Randhawa AK, Ziltener HJ, Stokes RW, (2008) CD43 controls the intracellular growth of Mycobacterium tuberculosis through the induction of TNF-α-mediated apoptosis. Cell Microbiol 10: 2105-2117.
54. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, et al. (2009) Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206: 2879-2888.
55. Brown GD, (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6: 33-43.
56. Yadav M, Schorey JS, (2006) The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108: 3168-3175.
57. Watkins MLV, Semple PL, Abel B, Hanekom WA, Kaplan G, et al. (2008) Exposure of Cord Blood to Mycobacterium bovis BCG Induces an Innate Response but Not a T-Cell Cytokine Response. Clin Vaccine Immunol 15: 1666-1673.
58. Hanekom WA, Hughes J, Mavinkurve M, Mendillo M, Watkins M, et al. (2004) Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods 291: 185-195.
59. Casanova J-L, Abel L, (2002) Genetic Dissection of Immunity to Mycobacteria: The Human Model. Annu Rev Immunol 20: 581-620.